Bicycle Therapeutics
BCYC
89 hedge funds and large institutions have $499M invested in Bicycle Therapeutics in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 15 closing their positions.
292% more call options, than puts
Call options by funds: $9.7M | Put options by funds: $2.47M
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
2% more funds holding
Funds holding: 87 → 89 (+2)
0.71% less ownership
Funds ownership: 79.19% → 78.48% (-0.71%)
28% less capital invested
Capital invested by funds: $696M → $499M (-$197M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
+$48.9M |
| 2 |
Morgan Stanley
New York
|
+$19.7M |
| 3 |
AC
Armistice Capital
New York
|
+$18.5M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$14.6M |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$37.3M |
| 2 |
SC
Samlyn Capital
New York
|
-$29.2M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$25.3M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.2M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$7.07M |
BCYC Hedge Fund Activity: Q1 2023 in Review
89 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2023, worth a combined $499M — down 28% from $696M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new BCYC positions and 15 closed out — a net gain of 3 holders — while 34 added to existing stakes and 17 trimmed.
The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $48.9M. The largest seller was RTW Investments, exiting entirely with an estimated $37.3M sold.
- 89 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2023, up from 87 in Q4 2022.
- Funds reported $499M of Bicycle Therapeutics stock for Q1 2023, down 28% quarter-over-quarter.
- 18 funds opened new Bicycle Therapeutics positions in Q1 2023 and 15 closed out, a net change of +3 holders.
- The largest Bicycle Therapeutics buyer in Q1 2023 was Jefferies Financial Group, an estimated $48.9M added.
- The largest Bicycle Therapeutics seller in Q1 2023 was RTW Investments, an estimated $37.3M sold.
Based on aggregated 13F filings for Q1 2023.